Ros Deegan

Ros Deegan is the founder of Impatient, a non-profit focused on crowdfunding Phase 2 medical trials. Ros is also head of Business Development at Trevena, a clinical-stage biopharmaceutical company in King of Prussia, PA.

Recent posts

Crowdfunding is Banging on Biotech’s Door. Will We Let It In?
In the summer of 2013, the medical device startup Scanadu made headlines around the world when Scout, its handheld medical diagnostic tool for consumers, raked in an astounding $1.6 million on... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Video
The Bay Area and Beyond: Biocom Talks Innovation and COVID
A Fireside Chat with Biocom President & CEO Joe Panetta
Biocom

From Our Editors · Special Report
Xcelerating Life Sciences San Francisco: Special Report
The AI, Big Data, and R&D Boom

Xconomy Insight · Special Report
How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook
Insights, wisdom, and inspiration on what it takes

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy National

Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4

FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats

Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

“Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

Lumen Bioscience Lands $16M to Engineer “Edible” Antibody Drugs

Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More

Bio Roundup: Grail Acquisition, Libra’s Launch, Tau Trial Results & More

Xcelerating Life Sciences New York

Ros Deegan

Recent posts

Crowdfunding is Banging on Biotech’s Door. Will We Let It In?

Underwriters and Partners

The Bay Area and Beyond: Biocom Talks Innovation and COVID

Xcelerating Life Sciences San Francisco: Special Report

How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook

Xconomy on Demand

We offer a number of ways to subscribe for free!